Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin

Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin

Abstract Background Zinc-α2-glycoprotein (ZAG) is a novel adipokine that reduces insulin resistance, protecting against type 2 diabetes. However, past studies have been contradictory. This cross-sectional study aims to investigate the association of circulating ZAG with metabolic syndrome (MetS) in...

Full description

Bibliographic Details
Main Authors: Lu Lei, Kejia Li, Ling Li, Xia Fang, Tingting Zhou, Cheng Zhang, Yong Luo, Hua Liu, Xiaoqiang Li, Hongting Zheng, Lin Zhang, Gangyi Yang, Lin Gao
Format: Article
Language:English
Published: BioMed Central 2017-08-01
Series:Nutrition & Metabolism
Subjects:
Zinc-α2-glycoprotein
Adiponectin
Metabolic syndrome
Insulin resistance
Online Access:http://link.springer.com/article/10.1186/s12986-017-0210-6

Internet

http://link.springer.com/article/10.1186/s12986-017-0210-6

Similar Items